Fusion Pharmaceuticals
a small molecule tat targeting receptor | Fusion Pharmaceuticals
Company
Deck Type
Sector
Industry
Deck date
November 2023
Slide
11 of 30
Similar slides by Fusion Pharmaceuticals
See diffirences between slides (animation)
Investor Presentation
January 2024
a small molecule tat targeting receptor | Fusion Pharmaceuticals
Investor Presentation
August 2023
a small molecule tat targeting receptor | Fusion Pharmaceuticals
Related slides by other companies
AN2 Therapeutics
Investor Presentation
February 2025
| AN2 Therapeutics
AN2 Therapeutics
Investor Presentation
March 2025
| AN2 Therapeutics
Vigil Neuroscience
IPO
January 2022
small molecule agonist selective for primate vigil | Vigil Neuroscience
Tenaya Therapeutics
IPO
July 2021
i small molecule program i | Tenaya Therapeutics
Other recent decks by Fusion Pharmaceuticals
See all presentations (4 decks)
Investor Presentation
January 2024
Investor Presentation
August 2023
IPO
June 2020
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights